189 related articles for article (PubMed ID: 17803969)
21. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
[TBL] [Abstract][Full Text] [Related]
22. CDC50A plays a key role in the uptake of the anticancer drug perifosine in human carcinoma cells.
Muñoz-Martínez F; Torres C; Castanys S; Gamarro F
Biochem Pharmacol; 2010 Sep; 80(6):793-800. PubMed ID: 20510206
[TBL] [Abstract][Full Text] [Related]
23. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
24. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast.
Cuesta-Marbán Á; Botet J; Czyz O; Cacharro LM; Gajate C; Hornillos V; Delgado J; Zhang H; Amat-Guerri F; Acuña AU; McMaster CR; Revuelta JL; Zaremberg V; Mollinedo F
J Biol Chem; 2013 Mar; 288(12):8405-8418. PubMed ID: 23335509
[TBL] [Abstract][Full Text] [Related]
25. Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
Semini G; Klein A; Danker K
Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147
[TBL] [Abstract][Full Text] [Related]
26. Antitumoral alkylphospholipids induce cholesterol efflux from the plasma membrane in HepG2 cells.
Ríos-Marco P; Jiménez-López JM; Marco C; Segovia JL; Carrasco MP
J Pharmacol Exp Ther; 2011 Mar; 336(3):866-73. PubMed ID: 21148684
[TBL] [Abstract][Full Text] [Related]
27. Differential dependence of the ingestion of necrotic cells and TNF-alpha / IL-1beta production by murine macrophages on lipid rafts.
Acosta-Pérez G; Maximina Bertha Moreno-Altamirano M; Rodríguez-Luna G; Javier Sánchez-Garcia F
Scand J Immunol; 2008 Oct; 68(4):423-9. PubMed ID: 18782272
[TBL] [Abstract][Full Text] [Related]
28. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
Fleer EA; Berkovic D; Grunwald U; Hiddemann W
Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
[TBL] [Abstract][Full Text] [Related]
29. Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
Estella-Hermoso de Mendoza A; Campanero MA; de la Iglesia-Vicente J; Gajate C; Mollinedo F; Blanco-Prieto MJ
Clin Cancer Res; 2009 Feb; 15(3):858-64. PubMed ID: 19188156
[TBL] [Abstract][Full Text] [Related]
30. Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis.
van der Luit AH; Budde M; Ruurs P; Verheij M; van Blitterswijk WJ
J Biol Chem; 2002 Oct; 277(42):39541-7. PubMed ID: 12183451
[TBL] [Abstract][Full Text] [Related]
31. Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine.
Van Der Luit AH; Budde M; Verheij M; Van Blitterswijk WJ
Biochem J; 2003 Sep; 374(Pt 3):747-53. PubMed ID: 12837133
[TBL] [Abstract][Full Text] [Related]
32. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
33. Lipid raft disruption prevents apoptosis induced by 2-chloro-2'-deoxyadenosine (Cladribine) in leukemia cell lines.
Takahashi E; Inanami O; Ohta T; Matsuda A; Kuwabara M
Leuk Res; 2006 Dec; 30(12):1555-61. PubMed ID: 16730061
[TBL] [Abstract][Full Text] [Related]
34. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy.
Vink SR; van Blitterswijk WJ; Schellens JH; Verheij M
Cancer Treat Rev; 2007 Apr; 33(2):191-202. PubMed ID: 17287087
[TBL] [Abstract][Full Text] [Related]
35. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
[TBL] [Abstract][Full Text] [Related]
36. Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipids.
Sánchez-Blanco A; Rodríguez-Matellán AG; Reis-Sobreiro M; Sáenz-Narciso B; Cabello J; Mohler WA; Mollinedo F
Cell Cycle; 2014; 13(21):3375-89. PubMed ID: 25485582
[TBL] [Abstract][Full Text] [Related]
37. Some new faces of membrane microdomains: a complex confocal fluorescence, differential polarization, and FCS imaging study on live immune cells.
Gombos I; Steinbach G; Pomozi I; Balogh A; Vámosi G; Gansen A; László G; Garab G; Matkó J
Cytometry A; 2008 Mar; 73(3):220-9. PubMed ID: 18163467
[TBL] [Abstract][Full Text] [Related]
38. Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption.
Yi JS; Choo HJ; Cho BR; Kim HM; Kim YN; Ham YM; Ko YG
Biochem Biophys Res Commun; 2009 Jul; 385(2):154-9. PubMed ID: 19445898
[TBL] [Abstract][Full Text] [Related]
39. Lipid efflux mediated by alkylphospholipids in HepG2 cells.
Ríos-Marco P; Segovia JL; Jiménez-López JM; Marco C; Carrasco MP
Cell Biochem Biophys; 2013 Jul; 66(3):737-46. PubMed ID: 23397419
[TBL] [Abstract][Full Text] [Related]
40. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
